The global cancer supportive care drugs market size was valued at USD 20.7 billion in 2016. It is projected to exhibit a CAGR of 1.8% over the forecast period. Supportive care in cancer focuses on prevention and management of symptoms and side-effects associated with cancer and its treatment.